Cost-effectiveness analysis of pharmaceutical care in hypertension and diabetes in Poland – a Markov model
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Presentations + Posters
- By: SKOWRON, Agnieszka (Jagiellonian University Medical College, Department of Social Pharmacy, Krakow, Poland)
- Co-author(s): Polak, Wioletta (Jagiellonian University Medical College, Krakow, Poland)
Pharmaceutical care (PC) is not reimbursed in Poland. Polish law enables reimbursement of new service only if it is cost effective.
To compare costs and effectiveness of PC and standard medical care (SMC) for hypertensive (HT) and/or diabetic (DM) patients.
community pharmacies and GP offices.
Markov models were The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.